The Quantum Group Files Four Addition... ( Company Expands IP Portfolio to Nine...)

The Quantum Group Files Four Additional Patents

Date:4/17/2008

Company Expands IP Portfolio to Nine Filings, with Additional Applications

Expected

WELLINGTON, Fla., April 17 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com) announced today that it has filed four additional provisional business process patents with the United States Patent and Trademark Office, adding to the five applications filed and announced in January 2008.

Collectively, these nine patents are considered to be strategic building blocks to the dynamic, multidimensional architecture the Company is constructing to address the communication obstacles the Company believes inherent in the coordination of patient care. Quantum deems that these current obstacles are due to the inability of patients to fully understand their current health analysis and the possible risk factors that affect them. The technology and IP behind the patents are the core components for building a technology platform that will allow doctors to use the latest practice automation to more effectively treat patients and promote wellness. Traditionally, the focus of the medical industry has been on reacting to the immediate, episodic events of a patient, rather than taking a proactive, preventative approach to wellness. A broader predictive medical logistics platform is expected to enrich the science of healthcare by driving unprecedented knowledge through information management, data mining and predictive modeling of trends and causes in a new, unexplored way.

Pete Martinez, Senior Vice President and Chief Technology & Innovations Officer of The Quantum Group, has led the team developing the technology and processes behind these patents. Martinez stated, "These patents represent the foundation of a platform that has the potential to modernize healthcare by simplifying the underlying processes and enhancing the overall quality
'/>"/>

SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
2. The Quantum Group Extends CEOs Employment Agreement
3. The Quantum Group Announces 1st Quarter Financial Results for Fiscal Year 2008
4. The Quantum Group Announces Strategic Technology Alliance
5. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
6. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
7. The Quantum Group, Inc. Announces Separation of Units
8. Results promising for computational quantum chemical methods for drug development
9. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
10. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
11. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers

Post Your Comments:

(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int

(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s

(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition

(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W

(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div

[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] Never Married, Over 40, Well-Adjusted [0] AVIVA's Private Health Insurance Products Solutions Go International [0] Distributor Announces New Applications for Wind Turbines [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share

...onor Hospital Excellence, KALAMAZOO, Mich., Sept....ed the Governor,s Award for Improving Patient,Safe... addition, 29,Critical Access hospitals statewide ...d(s) in partnership with,MPRO, Michigan,s Quality ...

...0, 2007) New evidenced-based guidelines from the ...end against the use of low-dose computed tomograph... Published as a supplement to the September issue ...nts, including those who are considered at high ri...

...be a sport where the,drivers are sitting while per... has to be as intense as any professional athlete....d to be mentally tough, as well,physically fit, so.../WebNR.aspx?story=33827 Oliver Gavin is four-tim...

...ascular surgery technique pioneered at UT Southwes...om the thigh to repair the aorta does not create b...ajority of patients, researchers report. , Vascul...aged aortas, the largest artery in the body, is ty...

...ains, olive oil lived 4 years longer, study found ...onsuming what,s known as a Mediterranean diet -- o...e oil -- may help Alzheimer,s patients live longer...ows on earlier work by the same team that suggests...

...rs determine out-of-pocket health care costs, CAM...troduced a new tool to help consumers compare heal...ir needs. The Plan Cost Advisor is available,to co... Customer Relationship Management.,"This is especi...

Other Medicine News:Health News:Michigan Hospitals Receive Governor's Award 2 Health News:Michigan Hospitals Receive Governor's Award 3 Health News:New lung cancer guidelines oppose general CT screening 2 Health News:New lung cancer guidelines oppose general CT screening 3 Health News:New lung cancer guidelines oppose general CT screening 4 Health News:Natural aorta grafts have few side effects for infection-prone patients 2 Health News:Mediterranean Diet May Boost Alzheimer's Survival 2 Health News:Mediterranean Diet May Boost Alzheimer's Survival 3 Health News:Mediterranean Diet May Boost Alzheimer's Survival 4 Health News:Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers 2

Michigan Hospitals Receive Governor's Award New lung cancer guidelines oppose general CT screening VIDEO from Medialink and General Motors: On and Off the Track Natural aorta grafts have few side effects for infection-prone patients Mediterranean Diet May Boost Alzheimer's Survival Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers

(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r

(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr

(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin

Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4 Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2 Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3 Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4 Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2 Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 1 Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 2 Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 3 Top Newport Beach Plastic Surgeon Appointed President of Orange County Society of Plastic Surgeons 55366 1 Top Newport Beach Plastic Surgeon Appointed President of Orange County Society of Plastic Surgeons 55366 2 eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 1 eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 2 eMindful Offers Employers Complete Set of Wellness Tools Partnership with Online Health Coaching Service Rounds Out Health Package 55361 3

[0] Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer [0] Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial [0] Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website

...sponse Network (LRN), the national laboratory syst...ergencies, will mark its first decade at its natio..., , Founded in 1999 by the Association of Public ...e Control and Prevention (CDC) and the Federal Bur...ioterrorism, the Laboratory Response Network has e...

.... (Nasdaq: ARNA ) today announced it will hold a...2009 at 8:30 a.m. Eastern Time (5:30 a.m. Pacific ...vioral modification and Lorcaserin for Overweight ...trials evaluating the safety and efficacy of lorca...and Chief Executive Officer, Dominic P. Behan, Ph....

Other Medicine Technology:Nation's Laboratory Response Network Marks First Decade of Protecting Public Health 2 Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results 2 Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results 3

Nation's Laboratory Response Network Marks First Decade of Protecting Public Health Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results

5F Infiniti

Softtouch

CT Micro Stereotactic System

Tapered Tefcor Movable Core Wire Guides

Medicine Products:

5F Infiniti Softtouch CT Micro Stereotactic System Tapered Tefcor Movable Core Wire Guides

The Quantum Group Files Four Addition...( Company Expands IP Portfolio to Nine...),Health